Skip to main content

ProQR Therapeutics N.V.

PRQR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612940

In the last 90 days, ProQR Therapeutics N.V. insiders filed 5 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in ProQR Therapeutics N.V. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
0 vs. Q2 2024
Shares held
17.4M
+157.2K (+0.9%) vs. Q2 2024
Total value
$31.7M
+$3.10M (+10.8%) vs. Q2 2024
New holders
5
9 more added
Sold out
5
15 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 47 institutions
Q1 2021: 64 institutionsQ2 2021: 63 institutionsQ3 2021: 67 institutionsQ4 2021: 74 institutionsQ1 2022: 58 institutionsQ2 2022: 51 institutionsQ3 2022: 47 institutionsQ4 2022: 46 institutionsQ1 2023: 55 institutionsQ2 2023: 51 institutionsQ3 2023: 46 institutionsQ4 2023: 47 institutionsQ1 2024: 49 institutionsQ2 2024: 48 institutionsQ3 2024: 47 institutionsQ4 2024: 77 institutionsQ1 2025: 65 institutionsQ2 2025: 62 institutionsQ3 2025: 64 institutionsQ4 2025: 65 institutionsQ1 2026: 69 institutionsQ2 2026: 70 institutions
Value heldQ3 2024: $31.7M
Q1 2021: $286.4MQ2 2021: $259.4MQ3 2021: $333.4MQ4 2021: $364.8MQ1 2022: $28.7MQ2 2022: $17.2MQ3 2022: $15.9MQ4 2022: $60.0MQ1 2023: $47.5MQ2 2023: $34.2MQ3 2023: $24.3MQ4 2023: $37.0MQ1 2024: $39.8MQ2 2024: $28.6MQ3 2024: $31.7MQ4 2024: $117.7MQ1 2025: $54.9MQ2 2025: $82.4MQ3 2025: $80.0MQ4 2025: $75.1MQ1 2026: $56.8MQ2 2026: $113.0M
Institutions holding PRQR and their total value by quarter
QuarterHoldersValue
Q2 202670$113.0M
Q1 202669$56.8M
Q4 202565$75.1M
Q3 202564$80.0M
Q2 202562$82.4M
Q1 202565$54.9M
Q4 202477$117.7M
Q3 202447$31.7M
Q2 202448$28.6M
Q1 202449$39.8M
Q4 202347$37.0M
Q3 202346$24.3M
Q2 202351$34.2M
Q1 202355$47.5M
Q4 202246$60.0M
Q3 202247$15.9M
Q2 202251$17.2M
Q1 202258$28.7M
Q4 202174$364.8M
Q3 202167$333.4M
Q2 202163$259.4M
Q1 202164$286.4M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q2 2024.

Institutions holding PRQR in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Privium Fund Management B.V.5,632,388$10.3M2.55%+51,663+0.9%Added
Adage Capital Partners GP, L.L.C.3,625,467$6.60M0.01%00.0%Unchanged
EcoR1 Capital, LLC1,835,991$3.34M0.11%−206,780−10.1%Reduced
M28 Capital Management LP1,019,498$1.86M2.04%00.0%Unchanged
DAFNA Capital Management LLC905,582$1.65M0.39%00.0%Unchanged
Ghost Tree Capital, LLC887,700$1.62M0.55%−12,300−1.4%Reduced
Macquarie Group Ltd620,000$1.13M0.00%00.0%Unchanged
Ikarian Capital, LLC483,583$880.1K0.27%00.0%Unchanged
Schonfeld Strategic Advisors LLC412,190$750.2K0.01%+350,290+565.9%Added
Monaco Asset Management SAM327,892$596.8K0.25%+15,263+4.9%Added
Morgan Stanley274,450$499.5K0.00%+196,508+252.1%Added
Franklin Street Advisors Inc150,000$273.0K0.02%00.0%Unchanged
Millennium Management LLC143,929$262.0K0.00%−4,428−3.0%Reduced
Deutsche Bank AG108,762$197.9K0.00%−276,387−71.8%Reduced
Boothbay Fund Management, LLC106,703$194.2K0.01%00.0%Unchanged
Acadian Asset Management LLC93,358$165.0K0.00%+89,425+2,273.7%Added
Two Sigma Advisers, LP87,500$159.3K0.00%−44,000−33.5%Reduced
Citadel Advisors LLC86,977$158.3K0.00%+68,612+373.6%Added
Bank of America Corp73,163$133.2K0.00%00.0%Unchanged
Squarepoint Ops LLC71,491$130.1K0.00%−13,242−15.6%Reduced
Two Sigma Investments, LP62,520$113.8K0.00%−6,425−9.3%Reduced
BNP Paribas Arbitrage, SA58,801$107.0K0.00%+7,300+14.2%Added
Resources Investment Advisors, LLC.57,550$104.7K0.00%+15,550+37.0%Added
Geode Capital Management, LLC46,671$84.9K0.00%00.0%Unchanged
Susquehanna International Group, LLP42,223$76.8K0.00%−53,895−56.1%Reduced
RFG Advisory, LLC42,000$76.4K0.00%+10,000+31.3%Added
Bank of Montreal30,000$54.9K0.00%00.0%Unchanged
JustInvest LLC21,429$39.0K0.00%00.0%Unchanged
Mariner, LLC18,334$33.5K0.00%00.0%Unchanged
Northern Trust Corp15,750$28.7K0.00%−182−1.1%Reduced
Prudential Financial Inc13,200$24.0K0.00%+13,200New
Atom Investors LP13,107$23.9K0.00%00.0%Unchanged
EP Wealth Advisors, LLC11,500$20.9K0.00%00.0%Unchanged
Csenge Advisory Group10,000$18.5K0.00%00.0%Unchanged
Truist Financial Corp10,000$18.2K0.00%00.0%Unchanged
Kestra Advisory Services, LLC10,000$18.2K0.00%00.0%Unchanged
Wells Fargo & Company9,226$16.8K0.00%−1,770−16.1%Reduced
Federation des caisses Desjardins du Quebec7,496$13.6K0.00%+7,496New
Advisor Group Holdings, Inc.7,250$13.2K0.00%−5,000−40.8%Reduced
BlackRock, Inc.3,945$7.18K0.00%+3,945New
UBS Group AG2,900$5.28K0.00%−24,646−89.5%Reduced
Flaharty Asset Management, LLC2,000$3.64K0.00%+2,000New
PFS Partners, LLC1,000$1.82K0.00%00.0%Unchanged
JPMorgan Chase & Co300$5460.00%−14−4.5%Reduced
TD Waterhouse Canada Inc.40$700.00%+40New
Royal Bank of Canada200$00.00%−855−81.0%Reduced
Lazard Asset Management LLC103$00.00%−173−62.7%Reduced
Two Sigma Securities, LLC0$00.00%−12,471−100.0%Sold out
Simplex Trading, LLC0$00.00%−6,628−100.0%Sold out
Group One Trading, L.P.0$00.00%−4,090−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−821−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−33−100.0%Sold out
BlackRock Inc.––––Not filed